Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study

The COVID-19 pandemic represents an excessive burden on health care systems worldwide and the number of patients who require special care in the clinical setting is often hard to predict. Consequently, there is an unmet need for a reliable biomarker that could predict clinical outcomes of high-risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Markuskova, Lucia, Javorova Rihova, Zuzana, Fazekas, Tomas, Martinkovicova, Anna, Havrisko, Martina, Dingova, Dominika, Solavova, Maria, Rabarova, Daria, Hrabovska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195767/
https://www.ncbi.nlm.nih.gov/pubmed/37209860
http://dx.doi.org/10.1016/j.cbi.2023.110557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195767/
https://www.ncbi.nlm.nih.gov/pubmed/37209860
http://dx.doi.org/10.1016/j.cbi.2023.110557

Ejemplares similares